| Parham Bahador, MD | |
|
6100 Harris Pkwy, Fort Worth, TX 76132-4101 | |
| (817) 433-5977 | |
| Not Available |
| Full Name | Parham Bahador |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 6100 Harris Pkwy, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518352954 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 307372 (Louisiana) | Secondary |
| 207Q00000X | Family Medicine | S1558 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Silverado Hospice-dallas/fort Worth | Addison, TX | Hospice |
| Medical City Fort Worth | Fort worth, TX | Hospital |
| Medical City Weatherford | Weatherford, TX | Hospital |
| Texas Health Harris Methodist Hospital Southwest F | Fort worth, TX | Hospital |
| Senior Care Of Stonegate | Fort worth, TX | Nursing home |
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
Ultra-tiny zinc oxide (ZnO) particles with dimensions less than one-ten-millionth of a meter are among the ingredients list of some commercially available sunscreen products, raising concerns about whether the particles may be absorbed beneath the outer layer of skin.
The appearance of infectious diseases in new places and new hosts, such as West Nile virus and Ebola, is a predictable result of climate change, says a noted zoologist affiliated with the Harold W. Manter Laboratory of Parasitology at the University of Nebraska-Lincoln.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
› Verified 7 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
Ultra-tiny zinc oxide (ZnO) particles with dimensions less than one-ten-millionth of a meter are among the ingredients list of some commercially available sunscreen products, raising concerns about whether the particles may be absorbed beneath the outer layer of skin.
The appearance of infectious diseases in new places and new hosts, such as West Nile virus and Ebola, is a predictable result of climate change, says a noted zoologist affiliated with the Harold W. Manter Laboratory of Parasitology at the University of Nebraska-Lincoln.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
› Verified 7 days ago
| Entity Name | Questcare Matrix Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740605492 PECOS PAC ID: 7719137397 Enrollment ID: O20121016000465 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
Ultra-tiny zinc oxide (ZnO) particles with dimensions less than one-ten-millionth of a meter are among the ingredients list of some commercially available sunscreen products, raising concerns about whether the particles may be absorbed beneath the outer layer of skin.
The appearance of infectious diseases in new places and new hosts, such as West Nile virus and Ebola, is a predictable result of climate change, says a noted zoologist affiliated with the Harold W. Manter Laboratory of Parasitology at the University of Nebraska-Lincoln.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
› Verified 7 days ago
| Entity Name | Parham Bahador Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043098635 PECOS PAC ID: 2769836253 Enrollment ID: O20231003000905 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
Ultra-tiny zinc oxide (ZnO) particles with dimensions less than one-ten-millionth of a meter are among the ingredients list of some commercially available sunscreen products, raising concerns about whether the particles may be absorbed beneath the outer layer of skin.
The appearance of infectious diseases in new places and new hosts, such as West Nile virus and Ebola, is a predictable result of climate change, says a noted zoologist affiliated with the Harold W. Manter Laboratory of Parasitology at the University of Nebraska-Lincoln.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Parham Bahador, MD 211 4th St, Alexandria, LA 71301-8421 Ph: (318) 769-5283 | Parham Bahador, MD 6100 Harris Pkwy, Fort Worth, TX 76132-4101 Ph: (817) 433-5977 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.
Ultra-tiny zinc oxide (ZnO) particles with dimensions less than one-ten-millionth of a meter are among the ingredients list of some commercially available sunscreen products, raising concerns about whether the particles may be absorbed beneath the outer layer of skin.
The appearance of infectious diseases in new places and new hosts, such as West Nile virus and Ebola, is a predictable result of climate change, says a noted zoologist affiliated with the Harold W. Manter Laboratory of Parasitology at the University of Nebraska-Lincoln.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.
Epigem, a high-tech British micro-engineering company, has challenged 15 students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces), to come up with solutions to prevent a dangerous carcinogen from contaminating milk.
› Verified 7 days ago
Jonathan A Lazarini, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Fort Worth, TX 76104 Phone: 903-353-2265 | |
Mrs. Adeline Galvez, Family Medicine Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 270, Fort Worth, TX 76104 Phone: 817-250-4987 | |
Fomundam Newnton Mbuh, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 4759 South Fwy Ste 101, Fort Worth, TX 76115 Phone: 817-382-0005 | |
Dr. Joane Baumer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Family Medicine Center, Fort Worth, TX 76104 Phone: 817-335-1034 | |
Evelyn Tobias-merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 Stadium Dr, Fort Worth, TX 76109 Phone: 817-257-7940 | |
Dr. Michael David Carletti, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Montgomery St, Fort Worth, TX 76107 Phone: 817-735-0278 | |
Jonathan Patrick Angel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Beach St Ste 104, Fort Worth, TX 76111 Phone: 817-831-1750 Fax: 817-831-1750 |